Women's Health: Worldwide Prescription Drug Markets - 3rd Edition

Kalorama Information
March 1, 2003
368 Pages - SKU: KLI821220
License type:
Table of Contents Search inside this report Related Reports Buy by the Section
Countries covered: Global

Women's Health: Worldwide Prescription Drug Markets - 3rd Edition

 
Special Offer. Now 25% off the original price of $3750.
During the last 25 years, there have been unprecedented advancements in the area of women’s health and there is widespread recognition of the importance of addressing conditions that overwhelmingly affect women. Likewise, pharmaceutical marketers have increasingly understood the potential that the women’s health market represents and the increasing clout female consumers are wielding in the prescription drug marketplace. Women’s Health: Worldwide Prescription Drug Markets is a comprehensive study of the pharmaceutical markets aimed at diseases and conditions that affect women.

Scope and Methodology

For this study, the worldwide prescription drug market for women’s health is discussed in total manufacturers’ revenues for the following product categories:

  • Autoimmune diseases
  • Cancer
  • Gynecological and Sexually Transmitted Diseases
  • Hormones
  • Osteoporosis
  • Urinary Disorders

The information and analysis presented in this report are based on an extensive survey of senior management in the prescription women’s health drug industry. Background information was obtained from a comprehensive search of published literature and reports obtained from various government, business, medical trade, and international journals. Key information from published literature was used to conduct interviews with over 62 industry executives and product managers to validate and obtain expert opinion on current and future trends in the women’s health industry. Interviews were also used to confirm and/or adjust market size and market share estimates, as well as in formulating market projections.

All market data are presented at the manufacturers’ level in current U.S dollars. The base year for data was 2002. Historical data are provided for each of the years 1997 through 2002, and forecast data are provided for each of the years 2003 through 2007. Historical, base year, and forecast data are provided for each market segment and subsegment. Market shares are provided for each market segment for the 2002 base year.




Additional Information

$36 Billion Women’s Health Prescription Drug Market to Double by 2008

New York, March 11, 2003 /PR Newswire — The worldwide market for prescription drugs for women’s health will nearly double by the year 2007, according to a new study released today by Kalorama Information. Manufacturers’ revenues for 2002 approached $36 billion, according to the study, and will be near $64 billion in the year 2007.

The study, Women’s Health: Worldwide Prescription Drug Markets, reveals that the market has been growing at nearly 17% over the past five years and predicts that growth will continue to be in the double digits for the foreseeable future. Growth will be supported by the aging of women around the world, particularly in the United States, and an increase in product demand spurred by a still-growing women’s health awareness movement should expand the total market significantly.

"The importance and potential in this market can be seen in the dynamism of the competitive landscape," notes Steven Heffner, acquisitions editor at Kalorama Information. "Pharmacia’s strong number-two position in women’s health certainly was a factor in Pfizer’s decision to move in, and generic companies are aggressively attacking the patent positions of top companies like number-one Merck. The opportunity is too large to ignore."

The study covers the products and markets for prescription drugs in all sectors of women’s health such as autoimmune diseases, cancer, gynecological infection and sexually transmitted disease, hormone-related indications (including menopause, contraception, and sexual dysfunction), osteoporosis, and urinary bladder disorders. The comprehensive report provides market size and growth projections, competitive market share, and epidemiologic and clinical trends for a wide range of individual conditions from breast cancer to yeast infection.

About Kalorama Information
Kalorama Information, an imprint of MarketResearch.com, supplies the latest in independent market research for the life sciences. For more information, contact Steven Heffner at 212-807-2634 or sheffner@kaloramainformation.com, or visit www.KaloramaInformation.com.

About MarketResearch.com
MarketResearch.com is the leading provider of global market intelligence products and services. With over 50,000 research publications from 350 research publishers, we offer instant online access to the world’s most extensive database of expert insights on global industries. Updated daily. For more information, contact Alison Williams at 301-468-3650 x203 or awilliams@marketresearch.com, or visit www.MarketResearch.com.

More Global Rheumatology/Arthritis Reports

Rheumatoid Arthritis: World Drug Market 2011-2021 by Visiongain
How will the market for rheumatoid arthritis treatments perform from 2011? Visiongain's report shows you potential revenues to 2021, discussing opportunities and prospects. Discover ...

Disease and Therapy Review: Rheumatoid Arthritis by Timely Data Resources, Inc.
The Rheumatoid Arthritis Disease and Therapy Review provides an overview of the disease and related conditions, with incidence and prevalence numbers and percentages for ...

Therapeutics and Biomaterials for Musculoskeletal Disease: Global Markets by BCC Research
The global market for musculoskeletal disease is currently approaching $45 billion. The overall 5-year compound annual growth rate (CAGR) is forecasted to be about ...

Rheumatoid Arthritis Therapeutics by Global Industry Analysts
This report analyzes the worldwide markets for Rheumatoid Arthritis Therapeutics in US$ Million.The report provides separate comprehensive analytics for US, Japan, Europe, Latin America and ...

Global Markets for Wedge Osteotomy Systems 2009 by Millennium Research Group
Global Markets for Wedge Osteotomy Systems 2009 The global wedge osteotomy system market comprises opening and closing high tibial osteotomy (HTO) and distal femoral osteotomy ...

See all reports like this >>

 

Share this report


Other tasks

 
 

Research Assistance

Ask a question
 

Related Markets


Rheumatology/Arthritis Reports

 
 

Free Alert Me service

Receive bi-weekly email alerts on new market research

Sign Up Today!